SCHEMBL4612903

SCHEMBL4612903

NC(=O)c1ccccc1-c1ncnc2[nH]cnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.50
▸ CSNK1A1 P48729 2/20 0.48
▸ TYRO3 Q06418 2/20 0.48
▸ DYRK1B Q9Y463 2/20 0.48
▸ DAPK3 O43293 1/20 0.48
▸ JAK2 O60674 1/20 0.48
▸ PRKD3 O94806 1/20 0.48
▸ MAP4K4 O95819 1/20 0.48
▸ PAK4 O96013 1/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ CSF1R P07333 1/20 0.48
▸ RET P07949 1/20 0.48
▸ MET P08581 1/20 0.48
▸ PDGFRB P09619 1/20 0.48
▸ PIM1 P11309 1/20 0.48
▸ FGFR1 P11362 1/20 0.48
▸ PDGFRA P16234 1/20 0.48
▸ PRKACA P17612 1/20 0.48
▸ FLT1 P17948 1/20 0.48
▸ LTK P29376 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29832249 1.00 PARP1 (0.50) PARP1CSNK1A1TYRO3DYRK1BDAPK3
SCHEMBL29467366 1.00 PARP1 (0.50) PARP1CSNK1A1TYRO3DYRK1BDAPK3
SCHEMBL18066324 0.94 PARP1 (0.48) PARP1CSNK1A1TYRO3DYRK1BDAPK3
SCHEMBL16619215 0.83 PARP1 (0.46) PARP1CSNK1A1TYRO3DYRK1BDAPK3
SCHEMBL18066310 0.81 PIM1 (0.47) PARP1CSNK1A1DYRK1BDAPK3PRKD3
SCHEMBL18066326 0.80 GSK3B (0.41) PARP1CSNK1A1TYRO3DYRK1BDAPK3
SCHEMBL18066303 0.79 PRKCI (0.47) PARP1PRKD3MAP4K4PAK4ABL1
SCHEMBL29665034 0.77 JAK2 (0.78) CSNK1A1TYRO3DYRK1BDAPK3JAK2
SCHEMBL16619167 0.77 RPS6KB1 (0.38) PARP1CSNK1A1TYRO3DYRK1BDAPK3
SCHEMBL16619412 0.77 RPS6KB1 (0.43) PARP1RPS6KB1AURKAPDPK1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907362-A1 AMIDE DERIVATIVES AS KINASE INHIBITORS Devgen NV (BE) 2008-04-09 — — EP claimed
WO-2007006547-A1 AMIDE DERIVATIVES AS KINASE INHIBITORS DEVGEN N.V. (BE) 2007-01-18 — — WO claimed
CN-109451740-B Cyclic dinucleotides for the treatment of disorders associated with STING activity, such as cancer 先天肿瘤免疫公司 2022-09-02 — — CN disclosed
EP-3894394-A1 CYCLOBUTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS Janssen BioPharma, Inc. (US) 2021-10-20 — — EP disclosed
EP-3781687-A1 NOVEL SUBSTITUTED RIG-I AGONISTS: COMPOSITIONS AND METHODS THEREOF Merck Sharp&Dohme Corp. (US) 2021-02-24 — — EP disclosed
WO-2020121122-A1 CYCLOBUTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS Janssen Biopharma, Inc. (US) 2020-06-18 — — WO disclosed
WO-2019204179-A1 NOVEL SUBSTITUTED RIG-I AGONISTS: COMPOSITIONS AND METHODS THEREOF MERCK SHARP & DOHME CORP. (US) 2019-10-24 — — WO disclosed
Send feedback